Disc Medicine IRON Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$63.5M-4.9% | -$60.53M+2.9% | -$62.32M-12.8% | -$55.25M-62.1% | -$34.09M-15.7% | ||
| $89K0.0% | $89K+2.3% | $87K+2.4% | $85K+325% | $20K+122% | ||
| $11.95M+18.9% | $10.04M+5.6% | $9.51M+13.0% | $8.42M+32.3% | $6.36M+46.8% | ||
| $2.74M+56.6% | $1.75M+90.6% | $918K+386% | -$321K+74.9% | -$1.28M— | ||
| -$8.73M-296% | $4.45M-10.3% | $4.95M+323% | $1.17M+132% | -$3.69M-258% | ||
| $4.55M+229% | $1.38M— | $0-100% | $681K-90.6% | $7.23M+448% | ||
| $12K+1,300% | -$1K— | $0-100% | $15K+200% | -$15K— | ||
| -$168K— | —— | —— | $72K-83.4% | $435K+495% | ||
| -$62.24M-43.7% | -$43.3M+9.4% | -$47.8M+0.2% | -$47.92M-15.8% | -$41.38M-50.1% | ||
| $0-100% | $20K-23.1% | $26K-27.8% | $36K-95.8% | $851K+89.5% | ||
| $152.07M+12.3% | $135.4M+0.3% | $135M+22.3% | $110.35M+46.2% | $75.47M+5.1% | ||
| $58.31M+126% | -$222.89M— | —— | —— | -$272.63M-19,019% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $1.01M-82.1% | $5.64M+269% | $1.53M+71.6% | $892K+55.1% | $575K-52.2% | ||
| $1.7M-99.2% | $216.68M+1,770% | $11.59M+1,199% | $892K-99.6% | $244.25M+748% | ||
| -$2.23M+95.5% | -$49.52M— | —— | —— | -$69.76M-34,434% | ||
| $640K-5.7% | $679K-4.2% | $709K0.0% | $709K+1.6% | $698K+253% | ||
| $1.07M-34.5% | $1.63M-6.2% | $1.74M-33.7% | $2.62M+3.7% | $2.53M+14.2% | ||
| $686K-81.7% | $3.75M+1,448% | $242K+476% | $42K-85.0% | $280K— | ||
| -$168K— | —— | —— | $72K-83.4% | $435K+495% | ||
| -$8.73M-296% | $4.45M-10.3% | $4.95M+323% | $1.17M+132% | -$3.69M-258% | ||
| $4.55M+229% | $1.38M— | $0-100% | $681K-90.6% | $7.23M+448% | ||
| $206K-2.4% | $211K0.0% | $211K+1.4% | $208K+0.5% | $207K+63.0% | ||
| $129K+4.0% | $124K+3.3% | $120K+2.6% | $117K+4.5% | $112K+2.8% | ||
| $12K+1,300% | -$1K— | $0-100% | $15K+200% | -$15K— | ||
| $152.07M+12.3% | $135.4M+0.3% | $135M+22.3% | $110.35M+46.2% | $75.47M+5.1% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $0-100% | $206.34M— | —— | —— | $234M— | ||
| $0-100% | $4.69M— | —— | —— | $9.39M— | ||
| $687K— | —— | $291K— | —— | $287K— | ||
| -$168K— | —— | —— | $72K-83.4% | $435K+495% | ||
| —— | $212.5K0.0% | $212.5K0.0% | $212.5K0.0% | $212.5K+18.4% | ||
| -$62.24M-43.7% | -$43.32M+9.4% | -$47.83M+0.3% | -$47.95M-13.6% | -$42.23M-50.7% | ||
| -$62.24M-43.7% | -$43.32M+9.4% | -$47.83M+0.3% | -$47.95M-13.6% | -$42.23M-50.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Disc Medicine generate?
- Disc Medicine (IRON) generated -$201.3M in operating cash flow over the trailing twelve months.
- What is Disc Medicine's free cash flow?
- After $82.0K of capital expenditures, Disc Medicine's free cash flow was -$201.3M over the trailing twelve months, down 95.5% year over year.
- Where does Disc Medicine's cash flow data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.